Radiopharmaceuticals Market
- 2026 年市場規模
- USD 9,150.0 Mn
- 2033 年預估規模
- USD 19,842.7 Mn
- 年複合成長率 CAGR
- 11.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Radiopharmaceuticals Market, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radioisotope (Technetium-99m, Fluorine-18, Gallium-68, Lutetium-177, Iodine-131, Actinium-225, Others), By Application (Oncology, Cardiology, Neurology, Others), By End User (Hospitals and Clinics, Diagnostic Imaging Centers, Nuclear Medicine Centers, Academic and Research Institutes, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global radiopharmaceuticals market is estimated to be valued at USD 9,150.0 Mn in 2026 and is expected to reach USD 19,842.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033. Radiopharmaceuticals are special drugs made of radioactive isotopes bound to pharmaceutical vectors for diagnostic imaging and targeted therapy. They selectively gather in specific tissues, organs or cellular receptors to help in the visualization of physiological processes and the delivery of radiation directly to diseased cells, especially in oncology. The market encompasses diagnostic agents used in PET and SPECT imaging and therapeutic agents used in targeted radionuclide therapy.
The global radiopharmaceuticals market is growing due to the rising prevalence of cancer, cardiovascular and neurological disorders, coupled with advances in nuclear medicine infrastructure, isotope production and molecular targeting. The growing adoption of targeted treatments is expanding radiopharmaceuticals beyond traditional diagnostic uses while strict requirements for manufacturing, handling, distribution and administration continue to define this highly specialized market.
Market Dynamics
The global radiopharmaceuticals market is driven by the rise in burden of cancer and other chronic diseases, increasing use of targeted radionuclide therapies and growing applications of positron emission tomography (PET) and single-photon emission computer tomography (SPECT). Rising investments in infrastructure development for nuclear medicine, isotope production and next-generation radiopharmaceuticals especially in emerging markets are other factors contributing to the market growth.
However, the growth of Radiopharmaceuticals market is limited by factors such as short half-life of isotopes, complex supply chains, stringent regulatory requirements, high manufacturing costs and lack of specialized professionals. Nevertheless, significant opportunities exist in theranostics, which combines diagnostic imaging with targeted treatment using molecularly matched radiopharmaceuticals. Advances in alpha-emitting radioisotopes such as Actinium-225, expanding therapeutic pipelines, broader clinical indications, and increasing collaborations among pharmaceutical companies, biotechnology firms, and research institutions are expected to create new avenues for market growth
Key Features of the Study
• This report provides in-depth analysis of the global radiopharmaceuticals market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global radiopharmaceuticals market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, GE HealthCare Technologies Inc., Cardinal Health, Inc., Curium Pharma, Lantheus Holdings, Inc., Bayer AG, Bracco Imaging S.p.A., Siemens Healthineers AG, Jubilant Pharmova Limited, and Telix Pharmaceuticals Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global radiopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiopharmaceuticals market
Market Segmentation
• Type Insights (Revenue, USD Mn, 2021 - 2033)
o Diagnostic Radiopharmaceuticals
o Therapeutic Radiopharmaceuticals
• Radioisotope Insights (Revenue, USD Mn, 2021 - 2033)
o Technetium-99m
o Fluorine-18
o Gallium-68
o Lutetium-177
o Iodine-131
o Actinium-225
o Others
• Application Technique Insights (Revenue, USD Mn, 2021 - 2033)
o Oncology
o Cardiology
o Neurology
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals and Clinics
o Diagnostic Imaging Centers
o Nuclear Medicine Centers
o Academic and Research Institutes
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Novartis AG
o GE HealthCare Technologies Inc.
o Cardinal Health, Inc.
o Curium Pharma
o Lantheus Holdings, Inc.
o Bayer AG
o Bracco Imaging S.p.A.
o Siemens Healthineers AG
o Jubilant Pharmova Limited
o Telix Pharmaceuticals Limited
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Radiopharmaceuticals Market, By Type
Global Radiopharmaceuticals Market, By Radioisotope
Global Radiopharmaceuticals Market, By Application
Global Radiopharmaceuticals Market, By End User
Global Radiopharmaceuticals Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Industry Trends
4. Global Radiopharmaceuticals Market, By Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Diagnostic Radiopharmaceuticals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Therapeutic Radiopharmaceuticals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Radiopharmaceuticals Market, By Radioisotope, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Technetium-99m
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Fluorine-18
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Gallium-68
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Lutetium-177
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Iodine-131
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Actinium-225
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Radiopharmaceuticals Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cardiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Radiopharmaceuticals Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Diagnostic Imaging Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Nuclear Medicine Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Radiopharmaceuticals Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o GE HealthCare Technologies Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Cardinal Health, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Curium Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Lantheus Holdings, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bracco Imaging S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Siemens Healthineers AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Jubilant Pharmova Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Telix Pharmaceuticals Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Radiopharmaceuticals Market' - Global forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們